<code id='58784A4EE7'></code><style id='58784A4EE7'></style>
    • <acronym id='58784A4EE7'></acronym>
      <center id='58784A4EE7'><center id='58784A4EE7'><tfoot id='58784A4EE7'></tfoot></center><abbr id='58784A4EE7'><dir id='58784A4EE7'><tfoot id='58784A4EE7'></tfoot><noframes id='58784A4EE7'>

    • <optgroup id='58784A4EE7'><strike id='58784A4EE7'><sup id='58784A4EE7'></sup></strike><code id='58784A4EE7'></code></optgroup>
        1. <b id='58784A4EE7'><label id='58784A4EE7'><select id='58784A4EE7'><dt id='58784A4EE7'><span id='58784A4EE7'></span></dt></select></label></b><u id='58784A4EE7'></u>
          <i id='58784A4EE7'><strike id='58784A4EE7'><tt id='58784A4EE7'><pre id='58784A4EE7'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:1973
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

          Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

          advertisement

          “Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Microsoft launches AI tool for clinical documentation through Epic
          Microsoft launches AI tool for clinical documentation through Epic

          NuanceImageGalleryMicrosoftonThursdaysaiditwilllaunchitsartificialintelligencetoolforautomatingclini

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          FDA sets aggressive timeline for overhauling inspection procedures

          AdobeWASHINGTON—FoodandDrugAdministrationofficialshopetofinishthisyearamassiveoverhaulofthewaytheage